New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2012
10:35 EDTWWW, TRIP, STM, MAS, GNW, FLEX, FBHS, BOOM, EW, CKEC, ACIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Arch Coal (ACI) upgraded to Buy from Fair Value at CRT Capital... Carmike Cinemas (CKEC) upgraded to Outperform from Neutral at Macquarie... Dynamic Materials (BOOM) upgraded to Buy from Hold at Auriga... Edwards Lifesciences (EW) upgraded to Outperform from Market Perform at Wells Fargo... Flextronics (FLEX) upgraded to Neutral from Underperform at BofA/Merrill... Fortune Brands Home & Security (FBHS) upgraded to Outperform at RBC Capital... Genworth (GNW) upgraded to Neutral from Underperform at BofA/Merrill... Masco (MAS) upgraded to Sector Perform from Underperform at RBC Capital... STMicroelectronics (STM) upgraded to Buy from Neutral at Goldman... STMicroelectronics upgraded to Neutral from Sell at Citigroup... TripAdvisor (TRIP) upgraded to Buy from Neutral at BofA/Merrill... Wolverine World Wide (WWW) upgraded to Buy from Hold at Jefferies.
News For ACI;CKEC;BOOM;EW;FLEX;FBHS;GNW;MAS;STM;TRIP;WWW From The Last 14 Days
Check below for free stories on ACI;CKEC;BOOM;EW;FLEX;FBHS;GNW;MAS;STM;TRIP;WWW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 15, 2014
07:27 EDTTRIPTripAdvisor price target raised to $105 from $94 at Credit Suisse
Subscribe for More Information
April 14, 2014
16:24 EDTEWOn The Fly: Closing Wrap
Subscribe for More Information
12:26 EDTEWOn The Fly: Midday Wrap
Subscribe for More Information
12:00 EDTEWEdwards Lifesciences rises 13.7%
Edwards Lifesciences is up 13.7%, or $10.01, to $82.98
10:51 EDTEWEdwards up after court limits sale of Medtronic's CoreValve in U.S.
Subscribe for More Information
10:30 EDTEWHigh option volume stocks: ZLTQ GLOG RHT SBAC EW
Subscribe for More Information
10:25 EDTEWEdwards Lifesciences rises sharply following court action, upgrades
Subscribe for More Information
10:02 EDTSTMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTEWEdwards Lifesciences rises 13.9%
Subscribe for More Information
09:00 EDTEWEdwards Lifesciences rises 11.3%
Edwards Lifesciences is up 11.3%, or $8.28, to $81.25
08:59 EDTEWOn The Fly: Pre-market Movers
Subscribe for More Information
08:12 EDTEWEdwards Lifesciences price target raised to $90-$91 from $82-$83 at Wells Fargo
Wells Fargo increased its price target on Edwards after a federal court granted a preliminary injunction limiting the sale of a competing product, Medtronic's (MDT) CoreValve. The firm said the injunction was a "major surprise," and estimates that the injunction could increase Edwards EPS by 15c in 2014 and 34c in 2015. Wells keeps an Outperform rating on the stock.
07:39 EDTEWEdwards Lifesciences upgraded to Buy from Fair Value at CRT Capital
Subscribe for More Information
06:22 EDTEWMedtronic downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
06:21 EDTEWEdwards Lifesciences upgraded to Neutral from Underweight at JPMorgan
Subscribe for More Information
06:11 EDTTRIPTripAdvisor recent pullback a buying opportunity, says Piper Jaffray
Subscribe for More Information
05:30 EDTSTMSTMicroelectronics downgraded to Sell from Neutral at UBS
UBS downgraded STMicroelectronics to Sell citing valuation.
April 13, 2014
15:10 EDTEWMedtronic says CoreValve ruling has no impact outside U.S.
Subscribe for More Information
April 12, 2014
19:50 EDTEWEdwards says court limits sale of Medtronic CoreValve system in U.S.
Edwards Lifesciences (EW) announced that the U.S. District Court for the District of Delaware granted a preliminary injunction limiting the sale of Medtronic's (MDT) CoreValve system in the United States. The court ordered the injunction to go into effect in seven business days. The hearing related to a federal jury decision in 2010 that CoreValve willfully infringes Edwards' U.S. Andersen transcatheter aortic valve replacement patent. At the conclusion of the hearing, Chief Judge Gregory Sleet ordered Edwards and Medtronic to confer on what instances the CoreValve device could continue to be used in the treatment of U.S. patients at centers currently trained on CoreValve. There is a large body of evidence demonstrating the safety and performance of the Edwards SAPIEN valves, and the company remains committed to ensuring patients have appropriate access to transcatheter therapy. This case was initiated by Edwards in 2008. On April 1, 2010, a federal jury found Medtronic willfully infringed Edwards' U.S. Andersen patent and awarded damages. In Nov. 2012, the U.S. Court of Appeals for the Federal Circuit affirmed the jury decision; in Oct. 2013, the U.S. Supreme Court declined to hear Medtronic's appeal. The patent involved in this suit is part of the Andersen family of patents. The U.S. Andersen patent was issued in 1995. A petition has been filed with the U.S. Patent and Trademark Office to extend this patent into early 2016. In a separate case, a federal jury in January found that Medtronic CoreValve had willfully infringed Edwards' U.S. Cribier transcatheter heart valve patent, and awarded damages to Edwards in that trial.
April 10, 2014
14:22 EDTTRIPTripAdvisor volatility increases on wide price movement
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use